Bloks | $1,500,000 | (Sep 26, 2024)
ujet.cx | $76,000,000 | (Sep 26, 2024)
DefectDojo | $7,000,000 | (Sep 26, 2024)
Constructive Bio
United Kingdom
- Whittlesford, Cambridge
- 25/09/2024
- Series A
- $58,000,000
With the power to skillfully write meaningful DNA sequences, we embark on a new era where precise control over biology and the manipulation of matter in our environment is possible.
Constructive Biology is a spin out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge.
Our platform allow us to fundamentally reprogram the genetic code, and make molecules that nature could not make before. We will use our technologies to biosynthesize new classes of enzymes, pharmaceuticals and biomaterials.
If you would like to join our team, get in touch!
- Industry Biotechnology Research
- Website https://www.constructive.bio/
- LinkedIn https://www.linkedin.com/company/constructive-bio/
Related People
Ola (Aleksandra) WlodekFounder
United Kingdom -
Greater Cambridge Area
I am a passionate and driven leader who aims to create innovative solutions for challenging problems that can be solved with biotechnology. My mission is to leverage my scientific background and entrepreneurial mindset to develop and commercialize novel therapies that can improve the lives of millions of patients. As the CEO of Constructive Bio, I lead a dynamic and diverse team of experts who are dedicated to advancing the field of synthetic genomics and programmable biomolecules
FluidLogic® | $15,000,000 | (Sep 26, 2024)
Tamnoon | $12,000,000 | (Sep 26, 2024)
Infact | $5,337,880 | (Sep 26, 2024)
Feno | $6,000,000 | (Sep 26, 2024)
hlpy | $20,073,258 | (Sep 26, 2024)
La Solive | $4,461,520 | (Sep 26, 2024)
Genespire | $51,969,485 | (Sep 26, 2024)
Flent | $776,762 | (Sep 26, 2024)
Outgo | $15,000,000 | (Sep 26, 2024)